OQS
APLT

Occudo Quantitative Strategies’s Applied Therapeutics APLT Stock Holding History

Occudo Quantitative Strategies’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-34,372
Closed -$73K – 1123
2022
Q1 		$73K Buy
+34,372
New +$92.1K 0.01% 1047

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Occudo Quantitative Strategies's APLT Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of Applied Therapeutics (APLT) in Q2 2022, closing a stake of 34,372 shares — an estimated $73K sold.

Occudo Quantitative Strategies first reported a position in APLT in Q1 2022 and held it in 1 quarter. The position peaked at $73K in Q1 2022. 53 funds tracked by Wall St. Rank hold APLT as of Q2 2022.

  • Occudo Quantitative Strategies reported no remaining Applied Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 34,372 Applied Therapeutics shares in Q2 2022, an estimated $73K.
  • Occudo Quantitative Strategies first reported a position in Applied Therapeutics in Q1 2022 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Applied Therapeutics position peaked at $73K in Q1 2022.
  • 53 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.